Phase 2 Acute Ischemic Stroke Clinical Trials
28 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 28 trials
Recruiting
Phase 2
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Acute Ischemic Stroke
Shanghai Pharmaceuticals Holding Co., Ltd300 enrolled28 locationsNCT05686642
Recruiting
Phase 2
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
Acute Ischemic Stroke
University of California, Los Angeles120 enrolled3 locationsNCT06440707
Recruiting
Phase 2
A Study of TAK-755 in Adults With Acute Ischemic Stroke
Acute Ischemic Stroke
Takeda222 enrolled1 locationNCT07392450
Recruiting
Phase 2
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Acute Ischemic Stroke
Basking Biosciences, Inc.228 enrolled24 locationsNCT06226805
Recruiting
Phase 2Phase 3
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Acute Ischemic Stroke
Corxel Pharmaceuticals740 enrolled83 locationsNCT06990867
Recruiting
Phase 2Phase 3
Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke
Acute Ischemic Stroke
Xiang Luo429 enrolled2 locationsNCT06696820
Recruiting
Phase 2
Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke.
Acute Ischemic Stroke
Changzhou Qianhong Bio-pharma Co., Ltd.320 enrolled1 locationNCT07396337
Recruiting
Phase 2Phase 3
Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion
Acute Ischemic StrokeMedium Vessel Occlusion
Xiang Luo382 enrolled1 locationNCT07302854
Recruiting
Phase 1Phase 2
A Study of the Safety, Tolerability and Preliminary Efficacy of B2065 in Patients With Acute Ischemic Stroke.
Acute Ischemic Stroke
Tasly Pharmaceutical Group Co., Ltd54 enrolled1 locationNCT07371624
Recruiting
Phase 2
Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management
StrokeAcute Ischemic StrokeThrombolysis
Shanghai East Hospital340 enrolled1 locationNCT07279259
Recruiting
Phase 2
Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy
Acute Ischemic Stroke From Large Vessel Occlusion
University of Pennsylvania20 enrolled1 locationNCT06904911
Recruiting
Phase 2Phase 3
UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX)
Acute Ischemic Stroke
Cytopeutics Sdn. Bhd.80 enrolled1 locationNCT06129175
Recruiting
Phase 2
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Acute Ischemic Stroke
Kunming Pharmaceuticals, Inc.300 enrolled23 locationsNCT07279493
Recruiting
Phase 1Phase 2
The Effect of GD-iExo-003 in Acute Ischemic Stroke
Acute Ischemic Stroke
Xuanwu Hospital, Beijing29 enrolled1 locationNCT06138210
Recruiting
Phase 1Phase 2
Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke
Acute Ischemic Stroke
Dongzhimen Hospital, Beijing72 enrolled1 locationNCT06857487
Recruiting
Phase 2
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
Acute Ischemic Stroke
The Florey Institute of Neuroscience and Mental Health80 enrolled7 locationsNCT05363397
Recruiting
Phase 2
HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
Acute Ischemic Stroke
Fujian Shengdi Pharmaceutical Co., Ltd.208 enrolled2 locationsNCT07233070
Recruiting
Phase 2
A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
Acute Ischemic Stroke
Shaanxi Micot Pharmaceutical Technology Co., Ltd.360 enrolled1 locationNCT07205328
Recruiting
Phase 2
A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS
Acute Ischemic Stroke AIS
Shenzhen Wingor Biotechnology Co., Ltd.60 enrolled1 locationNCT07084012
Recruiting
Phase 2Phase 3
Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke
Acute Ischemic Stroke AIS
Shanghai Yueyang Integrated Medicine Hospital66 enrolled1 locationNCT07003386